Cargando…
Dendritic Cell Immunoreceptor Is a New Target for Anti-AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors
The HIV-1 pandemic continues to expand while no effective vaccine or cure is yet available. Existing therapies have managed to limit mortality and control viral proliferation, but are associated with side effects, do not cure the disease and are subject to development of resistance. Finding new ther...
Autores principales: | Lambert, Alexandra A., Azzi, Arezki, Lin, Sheng-Xiang, Allaire, Geneviève, St-Gelais, Karianne P., Tremblay, Michel J., Gilbert, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706466/ https://www.ncbi.nlm.nih.gov/pubmed/23874461 http://dx.doi.org/10.1371/journal.pone.0067873 |
Ejemplares similares
-
Three-dimensional modeling of DCIR and identification of new drugs blocking HIV-1 attachment and propagation
por: Gilbert, Caroline, et al.
Publicado: (2012) -
HIV-1 Induces DCIR Expression in CD4(+) T Cells
por: Lambert, Alexandra A., et al.
Publicado: (2010) -
Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain
por: Bloem, Karien, et al.
Publicado: (2013) -
Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity
por: Bellini, Rossella, et al.
Publicado: (2023) -
A Replication Study Confirms the Association of Dendritic Cell Immunoreceptor (DCIR) Polymorphisms with ACPA - Negative RA in a Large Asian Cohort
por: Guo, Jianping, et al.
Publicado: (2012)